Lightsense Technology

Public Health Detection Simplified

Lightsense Technology

Public Health Detection Simplified

Tucson, AZ
Data/Analytics
Health Tech
At Lightsense, we use optics, along with machine learning and analysis to provide better solutions for critical areas of public health like food safety, the overuse of antibiotics, and the opioid crisis. That’s why we developed a revolutionary new multispectral technology platform to redefine spectroscopy - providing a new generation of spectroscopic tools for analyzing materials and biological systems. Our company is pre-revenue and in prototyping stages with multiple patents and partnership paths underway.

$152,687

raised
$744,415
previously crowdfunded
44
Investors
$18M
Valuation
$8.57
Price per Share
$351.37
Min. Investment
Preferred
Shares Offered
Equity
Offering Type
$2M
Offering Max
Reg CF
Offering

$152,687

raised
$744,415
previously crowdfunded
44
Investors
$18M
Valuation
$8.57
Price per Share
$351.37
Min. Investment
Preferred
Shares Offered
Equity
Offering Type
$2M
Offering Max
Reg CF
Offering

Stack Owner's Bonus & Rewards!

Members get an extra 10% shares in addition to rewards below!

Rewards

Get rewarded for investing more into Lightsense Technology:

$351+
Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$1,000+
Investment
$1,000+
Invest $1,000+ and receive 2% Bonus Shares.
$5,000+
Investment
$5,000+
Invest $5,000+ and receive 5% Bonus Shares.

Reasons to Invest

  • We provide unique solutions to intractable problems in public health.
  • Our unique EPS technology is applicable to many important and growing markets.
  • Lightsense has a strong and experienced management team with innovative differentiated products powering future SaaS and disposable revenue pathways.




OVERVIEW


At Lightsense, we’re breaking new ground in public health

That’s because we are translating expensive, tabletop spectrometer instrumentation into miniaturized, handheld platforms - all with AI/ML powered optical detection technology that can serve a wide range of analytical applications.



Our focus is on utilizing this new class of tools to help solve some major problems in public health - such as detecting fentanyl and other illicit drugs in the opioid epidemic, detecting viral pathogens in the COVID-19 pandemic, as well as detecting bacterial pathogens in the food safety field.



We are a diverse and experienced group of successful scientists, engineers, and entrepreneurs focused on using modern optics techniques (especially miniaturized spectroscopy), advances in sensors and machine learning to attack problems related to public health in new, insightful ways.



THE PROBLEM


Public Health is facing some critical problems


In all the critical areas of public health - the common thread is that detection and testing solutions need to be faster, less expensive and more accurate. 


THE SOLUTION


Meet the Multispectral Point-of-Need Analyzers

Lightsense has developed a multi-spectral technology platform, the patented “Enhanced Photodetection Spectroscopy” (EPS) , a radical new spectroscopy architecture, for chemical, molecular and pathogen identification. 

 

Our devices can address critical analytical and detection problems in multiple areas of public health -  like rapid detection of illicit drugs, rapid screening for viral/bacterial pathogens, and monitoring bacterial pathogens in various parts of the food supply chain.




When it comes to the science: Spectroscopy uses light of many wavelengths to analyze objects or chemical compounds. This light energy interrogates the molecule of interest and produces a spectral response - creating what scientists call a “spectral fingerprint.” This fingerprint contains large amounts of data, and with our multispectral approach, data fusion and analysis, we can increase sensitivity. AI/ML can be used to detect known patterns and monitor samples, like in the three mentioned areas of public health, above, where we are creating solutions and partnerships.  




Machine Learning is a critical feature in our technology. It not only uses algorithms to detect patterns otherwise not visible and predict outcomes, EPS spectra contain large amounts of data which are aggregated in Cloud databases, allowing monetizing them as a new subscription service. 



Our business model includes both hardware and SaaS components. What makes us unique is a radical new and patented spectroscopy that integrates three or more individual spectroscopies with data fusion and machine learning analytics. Our miniaturization technology allows the construction of integrated small and handheld instruments. 

 

Our IP can also be licensed along with products in specific domain applications. Unique solutions can be crafted for individual partners and customers justifying licensing agreements and related higher margins.


We project our various hardware platforms to cost between $5K and $20K, and we believe we can outperform more expensive competing products, both in performance and in simplicity and ease of use. We project additional revenue from software (SaaS subscriptions) and for certain applications, disposable sample holders. 







THE MARKET


Applications in a Multitude of Industries 

Our applications and technology will find applications beyond traditional areas of Public Health. We anticipate that our devices will address critical analytical and detection problems in a wide range of large vertical markets.

 

Here’s the Total Addressable Markets (TAMS) from our initial focus markets. 




Lightsense miniaturized handheld spectrometers can be used in a variety of analysis applications with performance comparable to that of laboratory instruments, but at a dramatically lower cost, and ease of use. 


Our handheld spectrometers, both current products and instruments under development, are lightweight, easy to use, accurate, faster, and less expensive than competing technologies. We believe our technology will reach a multitude of industries.

Our Traction


Completed first raise, and accelerating with a second

We completed our first seed “A1” raise with SeedInvest, and will accelerate our developments with a second “A2” seed round now. 


Among our recent accomplishments, we received a Food and Beverage Magazine Award for the top 10 food safety solutions providers (Source).

 

The basis for the Lightsense technology portfolio has been developed by a seasoned and accomplished team over many years. Collectively, we’ve been granted over 150 patents in our careers, on a wide range of technologies.  


Currently, the Lightsense patent portfolio lineup includes:

  • 7 issued or allowed patents on miniaturized spectrometers and EPS multi-spectral designs, including both Lightsense owned and exclusively licensed
  • 4 patent applications
  • Multiple patent applications in preparation


WHY INVEST


Providing more and sensitive data for machine learning


By focusing on new techniques for sample preparation and data analysis, as well as advances in sensors and machine learning -  we expect to enable new solutions in areas of public health with very high sensitivity and easy-to-use products that are efficient and lower cost. 


Success for us looks like ..

  • Growing revenue and margin in our targeted areas, along with increased government contracts and awards to further our scientific foundations
  • Having robust and profitable partnerships in 3-4 market segments that utilize our technologies in different ways




THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.


Bold (⌘B)

In the Press

Food and Beverage Technology Review

Lightsense Technology - A game changer in pathogen detection

Offering Summary


Company

:

Lightsense Technology, Inc.

Corporate Address

:

7080 N CATHEDRAL ROCK PL, Tucson, AZ 85718

Offering Minimum

:

$10,001.19

Offering Maximum

:

$2,000,006.61

Minimum Investment Amount

(per investor)

:

$351.37











Terms


Offering Type

:

Equity

Security Name

:

Series Seed Preferred Stock

Minimum Number of Shares Offered

:

1,166

Maximum Number of Shares Offered

:

233,373

Price per Share

:

$8.57

Pre-Money Valuation

:

$18,018,125.05











*Maximum number of shares offered subject to adjustment for Bonus Shares. See Bonus Share info below.


Company Perks*


Audience-Based:

5% Bonus Shares for previous investors.

 

Time-Based:

Friends and Family Early Birds

Invest within the first 96 hours and receive 10% Bonus Shares.

Early Bird Bonus

Invest after the first 96 hours but within the first two weeks and receive 5% Bonus Shares.

 

Amount-Based (not "stacked" with time-based):

$1,000+

Invest $1,000+ and receive 2% Bonus Shares.

$5,000+

Invest $5,000+ and receive 5% Bonus Shares.

*All perks occur when the offering is completed.


The 10% StartEngine Owners' Bonus


Lightsense Technology will offer 10% additional Bonus Shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. Owner's bonus.


This means eligible StartEngine shareholders will receive a 10% Bonus Shares for any shares they purchase in this offering. For illustration, if an eligible StartEngine investor buys 100 shares of Series Seed Preferred Stock at $8.57 / share, that investor will receive 110 shares of Series Seed Preferred Stock, for an aggregate purchase price of $857. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.


This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.


Subject to the provision related to the Owner's Bonus in the sentence following, Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus and the Previous Investors' Bonus in addition to the aforementioned bonus.

As provided in the Company’s Restated Certificate of Incorporation, attached as Exhibit F, the issuance of Bonus shares to an investor will lower the per-share price of all such shares issued to such investor to reflect the issuance of such additional Bonus Shares (i.e., the Bonus Shares will have the same (lower) per-share price as all other shares being purchased, determined by dividing the total purchase price paid by the investor by the total number of shares acquired (including any Bonus Shares)—for illustration, if an investor purchases 100 shares for an aggregate investment of $875 and receives 10% Bonus Shares (resulting in 110 total shares), the per-share price (“Original Issue Price”) of each share issued to such investor (including each Bonus Share) will be deemed to be $7.7009 per share).

The Company will not incur any irregular use of proceeds.


Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$910,771.00 USD
$50,850.00 USD
Cash And Cash Equivalents
$803,310.00 USD
$24,969.00 USD
Accounts Receivable
$0.00 USD
$16,549.00 USD
Short Term Debt
$0.00 USD
$0.00 USD
Long Term Debt
$569,382.00 USD
$514,131.00 USD
Revenues And Sales
$88,747.00 USD
$25,949.00 USD
Costs Of Goods Sold
$1,040.00 USD
$2,040.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$342,094.00 USD
-$69,896.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Lightsense Technology and Strategic Group International Announce Field Test of the new “DrugDetect-F1” in Morris County, New Jersey

3 days ago

Real-world trial with US Law Enforcement of new Illicit Drug Detection Device for Fentanyl

 

August 12, 2022— Tucson, AZ — Lightsense Technology, a pioneer in developing multi-spectroscopic solutions to address large problems in public health—from the opioid crisis to pandemics and even food safety —announced today a new field test of its DrugDetect-F1 device (for the safe and efficient detection of fentanyl in the field), with the Sheriff’s Office in Morris County NJ.

 

"We are pleased to announce this upcoming trial program with Lightsense Technology, and their innovative DrugDetect platform”, said Sheriff James Gannon. The DrugDetect-F1 seems lightweight and easy to use, but we want to get it in the field for real feedback from our people in various situations. We are also looking forward to seeing how this helps our officers in real-world situations, where the safety of our force and the public is always our highest priority.”

 

“This is a great chance to see the DrugDetect-F1 in the field, and Morris County (under the leadership of Sheriff Jim Gannon) is a perfect partner for us to team up with and get a real-world evaluation and direct feedback”, said 

Lenny Lemer Muñiz, CEO of Strategic Group International, LLC (“SGI”). “We are happy to be working with Lightsense to bring solutions like this to market and to help law enforcement officers do their job better and more safely, in these challenging times.”

 

The DrugDetect platform provides a solution that is easy to operate and offers great sensitivity with high levels of accuracy at a moderate price point. This platform can help with the difficult opioid epidemic by providing a new tool for law enforcement to tell quickly, if a white powdery substance inside a thin plastic bag could be a specific threat, helping them do their job efficiently and with less exposure to possible harm.

 

“We are very happy to have this opportunity to work with Sheriff Gannon and his talented team, and we look forward to this trial program providing real value to all involved,” said Terje Skotheim, CEO of Lightsense Technology. “The men and women in this office work every day to help keep their community safe, and we are proud to help provide solutions which can help keep them safer as well.”

 

INVEST in a better future for all, see our new campaign page for our SEED round with StartEngine, at, https://www.startengine.com/lightsense-technology

 

About Lightsense Technology

Lightsense has developed groundbreaking multi-spectral technology platforms, such as the patented “Enhanced Photodetection Spectroscopy” (EPS), a radical new spectroscopy architecture, for chemical, molecular, and pathogen identification. Their advanced miniaturized high-sensitivity spectrometer designs also enable new lightweight and inexpensive handheld devices to support solutions for law enforcement organizations, and beyond. These devices can address critical analytical and detection problems in a wide range of large vertical markets in “public health”, such as rapid detection of illicit drugs, rapid screening for viral/bacterial pathogens, and more. For more information, visit  www.lightsensetechnology.com 

About Strategic Group International (SGI)

Strategic Group International, LLC provides experienced law enforcement and federal programs experts, who assist public agencies in crime reduction and threat response in their communities. SGI also provides its Private Sector clients with guidance throughout the process of planning and executing homeland security and critical business operational tasks, and in a variety of security and preparedness-related programs, including crisis management. SGI also acts as an advisor to the United States Department of State, in support of various Mexico-based law enforcement advisory and training programs. SGI is securing cities across the globe, one community at a time. See https://sgi-llc.com/

Lightsense and Partner Universities Progress

6 days ago

Lightsense is pursuing multiple programs with various partner universities in the USA this summer with sponsored graduate students. Together, we will further develop our capabilities in both pathogen detection for food safety (with detailed bacterial growth and detection programs) and the related machine learning processes and code environment specific to our EPS measurements and devices. We are very excited about the preliminary research and our graduate students are excited to continue work on the programs during the upcoming school year.

Our Community Joins In! | Insider Investment Notice

10 days ago

We're excited to see our community come in and invest in LightSense!

Our insiders or family of insiders have invested a total of $2,451 into the offering out of the $150K that is raised thus far after the minimum funding goal was reached. 

We hope you join in as well! Invest in LightSense today!

Please refer to the Company’s offering materials for further information and refer to the Company’s Risk Factors.


DrugDetect-F1 Product Launch Update

10 days ago

We have received positive interest from our law enforcement community around the launch of our new DrugDetect-F1 product. We will soon be announcing some trial programs as well as upcoming trade show participation and related partnerships to work on promoting and supporting this product in the market, enabling safe and more efficient law enforcement.

Investments in Lightsense Reach New Milestones.

20 days ago

We are pleased to announce that last week, Lightsense Technology,  surpassed the $100k milestone with this new StartEngjne Seed round , and today , Monday, July 25, 2022, we are excited to announce we just surpassed the $150k milestone on our quest to help solve important public health issues with Physics, AI/ML, and our advanced spectroscopy - supporting a better possible future for us all. Thank you all very much for your support in this campaign.

Lightsense Receives Most Momentum Label on StartEngine Homepage!

24 days ago

Last week, in our first week of fundraising, Lightsense was awarded the distinction of being one of the few companies to be labeled as the "most momentum" on the StartEngine homepage.

We are very proud of this achievement and we thank you all for your support!

Lightsense Technology and Severn Safety Supply Announce Sales Channel Partnership for DrugDetect-F1

about 1 month ago

TUSCON, AZ –July 14, 2022 —Lightsense Technology, a pioneer of multi-spectroscopic solutions to address large problems in public health — from the opioid crisis to the pandemic, food safety and quality assurance in various supply chains — and Severn Safety Supply, a trusted supplier to Law Enforcement Organizations (LEOs) across the USA, today announced a strategic partnership to help bring the newly launched DrugDetect-F1 to markets in specific areas of North America, utilizing their unique skills and relationships.

 

"We are thrilled to partner with Lightsense Technology to help gain wider recognition of their innovative platform solution for illicit drug detection in the law enforcement community.” said Jeff Hall, President of Severn Safety Supply. “The DrugDetect-F1 will allow safer and more efficient operations for officers, and help combat the scourge of illicit drugs impacting various parts of our country.”

 

The DrugDetect-F1 provides a solution that is easy to operate and offers great sensitivity with high levels of accuracy at an inexpensive price pointThis platform can help with the difficult opioid epidemic by providing a new tool for law enforcement to determine whether a threat is present, even through thin transparent packaging, enabling them to perform their job more quickly, efficiently, and safely.

 

“We are pleased to be working with such experienced professionals like the Severn Safety Supply team, to reach more organizations with our unique new tools to help with our country’s growing opioid epidemic,” remarked Bruce Berkoff, CMO of Lightsense Technology. “The DrugDetect-F1 serves as compelling evidence of the power of our new light-based handheld spectroscopic detection technologies, and we could not ask for a better partner to help us introduce this valuable new product.”

 

About Lightsense Technology, Inc.

Lightsense has developed groundbreaking multi-spectral technology platforms, such as the patented “Enhanced Photodetection Spectroscopy” (EPS), a radical new spectroscopy architecture, for chemical, molecular and pathogen identification. Their advanced high-sensitivity mini-spectrometer designs also enable new lightweight and inexpensive handheld devices to address large vertical markets in “public health”, such as detection of illicit drugs, rapid screening for viral/bacterial pathogens, and monitoring bacterial pathogens in  the food supply chain. For more information, visit www.lightsensetechnology.com, or call 1-888-736-7349, #701. Also write, info@lightsensetechnology.com.  All products are Designed, Made, & Calibrated in the USA

INVEST in a better future for all, see our new campaign page for our SEED round with  StartEngine, at, https://www.startengine.com/lightsense-technology

 

About Severn Safety Supply LLC

Severn Safety Supply LLC is a California DGS certified Small/Micro Business and Disabled Veteran Business Enterprise and a SBA certified Service Disabled Veteran Owned Business (SDVOB) located in Benicia, California.  Severn Safety Supply has over 25 years of experience in law enforcement, military, and emergency vehicle equipment, personal safety apparel and equipmentVisit us at www.severnsafetysupply.com

View our Pitch Deck!

about 1 month ago

We're excited and grateful for everyone who has invested so far!  

 

At Lightsense, we use spectroscopy, optics, machine learning, and data analysis to provide better solutions for critical areas of public health like food safety, the overuse of antibiotics, and the opioid crisis.

 

We're passionate about our mission and hope you decide to come along and Invest Today!

 

We wanted to share our Pitch Deck with all of you as we believe it is a great resource with information on us and what we're about.

 

Please view our Pitch Deck here! 

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}